Medicare Enrolled
Dr. Daniel Roeter, M.D.
Urology Physician · Bellingham, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Roeter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Roeter?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Roeter
Dr. Daniel Roeter is an urology physician in Bellingham, WA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Roeter performed 1,746 Medicare services across 1,122 unique beneficiaries.
Between the years covered by Open Payments, Dr. Roeter received a total of $6,218 from 65 pharmaceutical and/or device companies across 291 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Roeter is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 29% volume in WA
$6,218 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,746
Medicare services
Top 29% in WA for urology physician
1,122
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~109 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 474 | $2 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
263 | $93 | $225 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
175 | $61 | $152 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
148 | $8 | $41 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
114 | $115 | $342 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
108 | $2 | $11 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
94 | $55 | $425 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
52 | $42 | $91 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
43 | $25 | $201 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
33 | $94 | $457 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
30 | $8 | $26 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
23 | $70 | $228 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
23 | $121 | $655 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $79 | $224 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
21 | $4 | $32 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
21 | $8 | $22 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
20 | $8 | $27 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
20 | $8 | $29 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
19 | $187 | $606 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
17 | $23 | $58 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
14 | $446 | $1,510 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
12 | $49 | $149 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
12.8% medium
85.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,218
Total received (2018-2024)
Avg $888/year across 7 years
Top 18% in WA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
291
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,878 (94.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$341 (5.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,235
2023
$925
2022
$1,360
2021
$505
2020
$269
2019
$1,115
2018
$808
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$325
Sumitomo Pharma America, Inc.
$138
ABBVIE INC.
$138
Janssen Biotech, Inc.
$119
C. R. Bard, Inc. & Subsidiaries
$74
ACCORD HEALTHCARE, INC.
$64
SUN PHARMACEUTICAL INDUSTRIES INC.
$39
Laborie Medical Technologies Corp.
$36
180 Medical, Inc.
$29
Astellas Pharma US Inc
$29
Boston Scientific Corporation
$27
Dendreon Pharmaceuticals LLC
$26
Ferring Pharmaceuticals Inc.
$25
Becton, Dickinson and Company
$24
Calyxo, Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$21
UROGEN PHARMA, INC.
$20
Olympus America Inc.
$20
Telix Pharmaceuticals
$20
PROCEPT BioRobotics Corporation
$20
Novartis Pharmaceuticals Corporation
$20
Top 3 companies account for 48.7% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$717
Boston Scientific Corporation
$527
Medtronic, Inc.
$465
Sumitomo Pharma America, Inc.
$336
PFIZER INC.
$276
Astellas Pharma US Inc
$265
Dendreon Pharmaceuticals LLC
$227
ABBVIE INC.
$176
Endo Pharmaceuticals Inc.
$166
Rochester Medical Corporation
$165
Coloplast Corp
$164
UROVANT SCIENCES INC
$164
Ferring Pharmaceuticals Inc.
$156
180 Medical, Inc.
$139
Bayer HealthCare Pharmaceuticals Inc.
$138
TOLMAR Pharmaceuticals, Inc.
$122
Amgen Inc.
$114
Intuitive Surgical, Inc.
$100
AbbVie, Inc.
$100
C. R. Bard, Inc. & Subsidiaries
$97
Blue Earth Diagnostics Limited
$90
Janssen Scientific Affairs, LLC
$90
Myovant Sciences Inc.
$85
Laborie Medical Technologies Corp.
$81
AbbVie Inc.
$79
Antares Pharma, Inc.
$66
ACCORD HEALTHCARE, INC.
$64
Sun Pharmaceutical Industries Inc.
$59
BOSTON SCIENTIFIC CORPORATION
$49
ConvaTec Inc.
$46
Progenics Pharmaceuticals, Inc.
$46
UroGen Pharma, Inc.
$44
PROCEPT BioRobotics Corporation
$44
UROGEN PHARMA, INC.
$43
Medtronic USA, Inc.
$43
Merck Sharp & Dohme LLC
$42
SUN PHARMACEUTICAL INDUSTRIES INC.
$39
Trevena, Inc.
$39
Bayer Healthcare Pharmaceuticals Inc.
$39
TherapeuticsMD, Inc.
$36
Merck Sharp & Dohme Corporation
$31
Travere Therapeutics, Inc.
$30
Myriad Genetic Laboratories, Inc.
$28
AMAG Pharmaceuticals, Inc.
$27
Teleflex LLC
$25
Becton, Dickinson and Company
$24
Calyxo, Inc.
$23
Retrophin, Inc.
$22
Olympus America Inc.
$20
Telix Pharmaceuticals
$20
Novartis Pharmaceuticals Corporation
$20
Augmenix, Inc.
$19
Profound Medical Corp.
$17
NeoTract Inc.
$17
Ethicon US, LLC
$16
Ambu Inc.
$16
Photocure Inc
$15
COLOPLAST CORP
$15
Kowa Pharmaceuticals America, Inc.
$15
AngioDynamics, Inc.
$15
Axonics, Inc.
$15
DENTSPLY IH Inc.
$13
Alnylam Pharmaceuticals Inc.
$13
UroMed, Inc.
$13
Allergan Inc.
$12
Top 3 companies account for 27.5% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · AVYCAZ · Advantage System · Axonics r-SNM System · Axumin · BOTOX · Bard Urinary Drainage Bag · CAMCEVI · CURE CATHETER · CVAC ASPIRATION SYSTEM · Cysview · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL - ONCOLOGY · GENTLECATH · General - Erectile Dysfunction · ILLUCCIX · IMVEXXY · INTERSTIM · INTRAROSA · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LoFric · Lupron · Lupron Depot · Myrbetriq · NANOKNIFE · NOCDURNA · Nubeqa · OBTRYX · ORGOVYX · OXLUMO · Olinvyk · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · PRECISETUMOR · PROVENGE · PYLARIFY · Prolaris · Prolia · REZUM · SEGLENTIS · SPEEDICATH · SURGICEL Family of Absorbable Hemostats · SUTENT · SpaceOAR · TITAN · TLANDO · TOVIAZ · Thiola · Titan · Tulsa-Pro · UROLIFT · UroLift · Veozah · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
8
Per 100K population
3.5
County median income
$80,989
Nearest hospital
ST JOSEPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Roeter is a clinical cardiology specialist, with above-average Medicare volume (top 29% in WA), with low-engagement industry engagement in the top 18% of WA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Roeter experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Roeter performed 474 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Roeter receive payments from pharmaceutical companies?
Yes. Dr. Roeter received a total of $6,218 from 65 companies across 291 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Roeter's costs compare to other urology physicians in Bellingham?
Dr. Roeter's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Roeter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Bellingham
Browse urology physicians in Bellingham ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in WA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in WA
Which WA urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology